Our screen of 73 patients with early-stage colorectal cancer (I–III) carrying a loss of one Smad4 allele identified two mutations of the remaining allele (3%), a finding that is in accordance with results described in the literature (Schutte et al, 1996; Miyaki et al, 1999). This evidence concerns the gene SMAD4 and colorectal cancer.